Pages that link to "Q35103006"
Jump to navigation
Jump to search
The following pages link to Differential gene expression in ovarian carcinoma: identification of potential biomarkers (Q35103006):
Displaying 50 items.
- Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells (Q24302552) (← links)
- Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy (Q26851347) (← links)
- The emerging roles of human tissue kallikreins in cancer (Q28290701) (← links)
- Identification of ovarian cancer metastatic miRNAs (Q28487932) (← links)
- Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4 (Q28534173) (← links)
- A novel integrated gene coexpression analysis approach reveals a prognostic three-transcription-factor signature for glioma molecular subtypes (Q28596425) (← links)
- Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response (Q30491616) (← links)
- A dynamic time order network for time-series gene expression data analysis (Q30583973) (← links)
- Gene expression data analysis in subtypes of ovarian cancer using covariance analysis (Q31076542) (← links)
- Linking the ovarian cancer transcriptome and immunome (Q33313203) (← links)
- Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation (Q33315705) (← links)
- NM23 as a prognostic biomarker in ovarian serous carcinoma (Q33327971) (← links)
- Comparative proteomics analysis of human gastric cancer (Q33374044) (← links)
- Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer (Q33484414) (← links)
- Pathogenesis of ovarian cancer: clues from selected overexpressed genes (Q33651139) (← links)
- Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors. (Q33764488) (← links)
- Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma (Q33768557) (← links)
- S1P metabolism in cancer and other pathological conditions (Q33886533) (← links)
- Ovarian cancer development and metastasis (Q34086819) (← links)
- Sphingosine 1-phosphate and cancer (Q34121255) (← links)
- Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients (Q34173955) (← links)
- PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein (Q34186659) (← links)
- Potential markers that complement expression of CA125 in epithelial ovarian cancer (Q34439240) (← links)
- S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival (Q34579314) (← links)
- Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker (Q34588329) (← links)
- C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin (Q34788669) (← links)
- Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation (Q34875061) (← links)
- Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease. (Q35147619) (← links)
- A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells (Q35157584) (← links)
- Protein tyrosine phosphatase-PEST and β8 integrin regulate spatiotemporal patterns of RhoGDI1 activation in migrating cells (Q35214716) (← links)
- The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer (Q35591623) (← links)
- Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor-deficient mutants (Q35613198) (← links)
- PAX Genes in Cancer; Friends or Foes? (Q35714437) (← links)
- Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin (Q35756974) (← links)
- Oncoproteomics: Trials and tribulations (Q35827653) (← links)
- Immunohistochemical Characterization of S100A6 in the Murine Ovary (Q35865646) (← links)
- Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence. (Q35926140) (← links)
- Epithelial-mesenchymal transition in ovarian carcinoma (Q35971814) (← links)
- Ultrasonographic contrast media: has the time come in obstetrics and gynecology? (Q36077557) (← links)
- Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells (Q36082365) (← links)
- Ovarian cancer metastasis: integrating insights from disparate model organisms (Q36111930) (← links)
- Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis (Q36122605) (← links)
- Mechanisms and Targets Involved in Dissemination of Ovarian Cancer (Q36180735) (← links)
- CRABP-II is a highly sensitive and specific diagnostic molecular marker for pancreatic ductal adenocarcinoma in distinguishing from benign pancreatic conditions (Q36210432) (← links)
- Anti-tumor antibodies in ovarian cancer. (Q36232263) (← links)
- Angiogenesis in normal and neoplastic ovaries (Q36279903) (← links)
- Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. (Q36613726) (← links)
- Mechanisms of transcoelomic metastasis in ovarian cancer. (Q36643128) (← links)
- Differential gene expression identifies subgroups of ovarian carcinoma (Q36673528) (← links)
- Immunoexpression and prognostic role of p53 in different subtypes of epithelial ovarian carcinoma (Q36682128) (← links)